Stock Detail
THERAGENICS CORPORATION
Sector: Drugs
Latest Quote @ Tue Jun 6 02:17:44 (15 min delayed)
| $1.93 |
$2.14 |
$2.02 |
-0.02 |
-0.98% |
|
Last Day's Data
| $2.02 |
$2.06 |
$0.00 |
0.00% |
0.00 |
$2.04 |
| $2.04 |
$2.02 |
48,235.00 |
60.89M |
69,862.00 |
31.78 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 2.07 |
2.04 |
2.03 |
2.00 |
1.99 |
Stock Profile
Theragenics Corporation provides brachytherapy and wound closure products. It operates through two segments, brachytherapy seed and CP Medical Wound Closure and Medical Products. The brachytherapy seed segment offers TheraSeed, a rice-sized palladium-103 device, used treat solid localized tumors, such as prostate cancer. This segment also manufactures and distributes I-Seed, an iodine-125 based medical device for the treatment of prostate cancer, as well as provides Intravascular Brachytherapy System that is designed to prevent restenosis or renarrowing of arteries. CP Medical Wound Closure and Medical Products segment manufactures and supplies sutures, cardiac pacing cables, brachytherapy needles/spacers/sleeves, and other related medical products for wound closure, cardiac pacing, and the general, dental, cosmetic and veterinary surgery markets. It distributes its products to physicians, hospitals, and other healthcare providers. Theragenics was incorporated in 1981 and is based in Buford, Georgia.
